Loading people...
Lisa Suennen is a prominent Venture Partner at Aphelion Capital, known for her extensive experience and leadership in healthcare venture capital, digital health, and life sciences investments. She is also a recognized thought leader and speaker in the healthcare innovation space.
Lisa Suennen invests in early-stage and growth-stage companies within the healthcare sector, focusing on areas such as digital health, healthcare IT, medical devices, and life sciences that aim to transform healthcare delivery and patient outcomes.
Lisa Suennen works as a Venture Partner at Aphelion Capital, a venture capital firm specializing in innovative investments.
Lisa Suennen is the Managing Partner at American Heart Association Ventures and a Venture Partner at Aphelion Capital, based in Mill Valley, California. In her primary role, she oversees $200 million in assets dedicated to translating cardiovascular and brain health science into commercial healthcare products. Her 35-year career includes previous General Partner positions at GE Ventures, Manatt Ventures, and Psilos Group, as well as serving as the President of Canary Medical. Earlier in her career, she operated as an executive at Merit Behavioral Care, helping scale the startup to $800 million in revenue before its initial public offering and subsequent acquisition by Magellan Health. Serving as a faculty member at the UC Berkeley Haas School of Business since 2009, Suennen focuses her current investments on advancing digital health, medical devices, and technology-enabled healthcare services.
Lisa Suennen serves as a highly respected Venture Partner at Aphelion Capital, where she plays a pivotal role in shaping the firm's investment strategy within the dynamic healthcare sector. Her work at Aphelion Capital centers on identifying and investing in groundbreaking companies across digital health, healthcare IT, medical devices, and life sciences. With a keen eye for disruptive innovation, Lisa seeks out ventures that promise to enhance patient care, improve operational efficiencies, and redefine the future of healthcare delivery.
Before joining Aphelion Capital, Lisa built an impressive career spanning several influential roles within the venture capital and healthcare industries. She was a Senior Managing Director at GE Ventures, leading their healthcare investing efforts and fostering strategic partnerships with innovative startups. Prior to GE Ventures, Lisa co-founded and served as a Managing Partner at Psilos Group, a healthcare-focused venture capital firm, where she spent over a decade investing in and building successful healthcare technology and services companies. Her tenure at Psilos Group established her as a leading voice and investor in the evolving healthcare landscape.
Lisa's extensive background also includes significant experience in strategic advisory and operational roles, providing her with a comprehensive understanding of the challenges and opportunities within the healthcare ecosystem. She is widely recognized for her thought leadership, frequently speaking at industry conferences and contributing articles on healthcare innovation, venture capital trends, and the intersection of technology and medicine. Her insights are highly valued by entrepreneurs and investors alike, making her a sought-after mentor and advisor.
Throughout her career, Lisa has been instrumental in the growth and success of numerous companies, though specific public "notable investments" are often attributed to the funds she managed rather than individual credit. Her investment philosophy emphasizes not just financial returns, but also the potential for positive societal impact through healthcare advancements. She is known for her strategic approach to portfolio management, working closely with founders to navigate market complexities, scale operations, and achieve sustainable growth. Her commitment to fostering innovation and driving meaningful change makes her an invaluable asset to Aphelion Capital and the broader healthcare investment community.
